2
Participants
Start Date
February 28, 2009
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
FOLFOX and bevacizumab
The patient will receive six treatments, two weeks apart. On each treatment day you will get Oxaliplatin, 5-FU,Leucovorin. On the first four treatments you will also get Bevacizumab (Avastin). These drugs are given through a Mediport. They will be given in an outpatient chemotherapy unit. Each tx will take about 4 hours. A pump for the 5-FU is worn around your waist. This drug is given over 2 days. Part II: Colon Cancer Surgery is standard practice, and is not a research procedure.Part III: Post-operative Re-Evaluation and Recovery The doctor will decide on the type of chemotherapy based on how the patient responded to the first chemotherapy. The plan will be for the patient to get 6 more doses of FOLFOX, without any further bevacizumab, unless your doctor finds a reason to do otherwise.
Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow
Collaborators (1)
Genentech, Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER